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Chronic kidney disease (CKD) is defined by the presence of 
abnormalities of kidney structure or function (such as a glomerular 
filtration rate (GFR) <60 mL/min/1.73 m2), present for >3 months, 
with implications for health.[1] The Kidney Disease: Improving Global 
Outcomes (KDIGO) guideline recommends using a creatinine-based 
equation to estimate GFR in the initial assessment of CKD and for 
monitoring disease progression.[1] The two most commonly used 
equations in adults are the Modification of Diet in Renal Disease 
(MDRD) equation[2,3] and the Chronic Kidney Disease Epidemiology 
Collaboration (CKD-EPI) equation.[4] Unless an alternative equation 
has been shown to have superior accuracy, use of the CKD-EPI 
equation is recommended.[1,5]
A 2012 systematic review found that neither the MDRD nor the 
CKD-EPI equation performed well in populations outside North 
America, Europe or Australia, and it concluded that neither equation 
could be used routinely across all populations and all GFR ranges. [6] 
Studies conducted in various South African (SA) populations support 
this, and although the findings varied, the equations tended to 
have unacceptable bias, precision and/or accuracy.[7-11] The poor 
performance of the equations in SA populations is concerning. 
SA is a developing country with limited centres that are able to 
measure GFR. Even where the service is available, the large number 
of CKD patients attending renal clinics precludes routine GFR 
measurement, compelling physicians to rely on estimated GFR 
(eGFR). Furthermore, GFR estimates are essential in epidemiological 
studies, specifically to determine CKD prevalence.
The mixed-ancestry (coloured) population group is estimated to 
comprise 8.8% of SA’s population[12] and almost 49% of the Western 
Cape Province population.[13] Its origins are Khoisan (32 - 43%), 
Bantu-speaking African (20 - 36%), European (21 - 28%) and Asian (9 - 
11%). [14] No previous studies have evaluated GFR-estimating equations 
in this group, despite the fact that it has a high prevalence of CKD.[15,16] 
Considering the population group’s genetic diversity, it is hypothesised 
that accuracy of the commonly used equations will be poor.
Objectives
To evaluate the performance of the MDRD and CKD-EPI equations 
in mixed-ancestry SA adults.
Methods
Participants
Participants were recruited from the outpatient clinics of the Divi-
sion of Nephrology at Tygerberg Hospital, Cape Town, between 
June 2015 and October 2018. Patients attending routine outpatient 
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appointments or individuals being worked up for potential kidney 
donation were screened by a renal physician to exclude acute 
renal failure, concurrent illness, cancer, expanded extracellular 
fluid volumes (ascites, oedema or pleural effusions), pregnancy 
or breastfeeding. After screening, adult patients (≥18 years) who 
self-classified as South Africans of mixed ancestry were invited to 
participate. All participants provided written informed consent. The 
study was approved by the Stellenbosch University Health Ethics 
Research Committee (ref. no. S14/10/217).
GFR measurement
GFR was measured in the Nuclear Medicine Division of Tygerberg 
Hospital following our departmental protocol, which is based on 
the methodology in the 2004 British Nuclear Medicine Society GFR 
guideline.[17] On arrival, the height and weight of the participant was 
recorded. Approximately 40 MBq of 99mTc-diethylenetetraaminepenta-
acetic acid (99mTc-DTPA) was injected through an intravenous catheter. 
Extravasation was excluded by imaging the injection site using a 
gamma camera. A similar dose of 99mTc-DTPA was used for preparation 
of the standard. Patient and standard doses were calibrated accurately 
by weighing the syringes before and after administration of the doses 
on a Precisa 620C balance (precision = 0.005 g) (Precisa Balances Ltd, 
UK). In order to avoid excessively high count rates, a double dilution 
of the standard was performed, resulting in an effective volume of 5 L. 
Duplicate 1 mL samples of the standard were pipetted into counting 
tubes. Venous blood samples were taken from the contralateral arm at 
2, 3 and 4 hours after 99mTc-DTPA administration. After centrifugation 
at 1 000 g for 10 minutes, duplicate 1 mL plasma samples were pipetted 
into counting tubes. The plasma and standard samples were counted 
simultaneously in a multichannel well counter (VIDEOGAMMA 4880; 
l’acn Scientific Laboratories, Italy) together with two empty counting 
tubes for background correction. GFR was calculated using the slope-
intercept method.[17,18] The clearance values obtained were corrected 
for body surface area (BSA) using the Haycock formula,[19] and to 
correct for the systematic underestimation of GFR that is inherent to 
the slope-intercept method, the mean Bröchner-Mortensen correction 
was applied.[17,20,21] Routine quality control checks were performed on 
each GFR study.
GFR estimation
A venous blood sample was taken for creatinine measurement 
immediately prior to administration of the 99mTc-DTPA dose. Serum 
creatinine (Scr) was measured by the Tygerberg Hospital National 
Health Laboratory Service. Initially a method based on the Jaffé 
reaction was used (Siemens ADVIA 1800; Siemens Healthineers, 
Germany). In September 2016, the analyser was replaced with a Roche 
Cobas 6000, c501 module (Roche, Switzerland), where an enzymatic 
method is applied. Both methods have been standardised against 
isotope dilution mass spectrometry. The analytical imprecision 
and total error of the Siemens Advia 1800 were 2.0% and 2.4%, 
respectively, at Scr 79 µmol/L, 2.1% and 7.2% at Scr 166 µmol/L, and 
1.8% and 6.7% at Scr 529 µmol/L. Values for the Roche Cobas 6000 
analyser were 1.9% and 2.4% at Scr 90.5 µmol/L, and 1.3% and 4.1% 
at Scr 327.9 µmol/L.
Estimated GFR was calculated using the following equations, both 
of which are corrected for BSA: 
1. The re-expressed, 4-variable MDRD equation:[3]
eGFR (mL/min/1.73 m2) = 175 × (Scr/88.4)–1.154 × age–0.203 × g × e,
 where Scr is serum creatinine in µmol/L, g is a gender factor 
(male  = 1, female = 0.742), and e is an ethnicity factor (African 
American = 1.212, other ethnic groups = 1).
2. The CKD-EPI equation:[4]
eGFR = 141 × min(Scr/κ,1)α × max(Scr/κ,1)–1.209 × 0.993age × g × e,
 where Scr is serum creatinine in µmol/L, κ is 61.9 for females 
and 79.6 for males, α is –0.329 for females and –0.411 for males, 
min(x,y) and max(x,y) indicate the minimum and maximum of x 
and y, respectively, g is a gender factor (male = 1, female = 1.108), 
and e is an ethnicity factor (African American = 1.159, other 
ethnic groups = 1).
Data analysis
Bias was calculated as the median difference between eGFR and 
measured GFR (mGFR). Precision was expressed as the interquartile 
range (IQR) of the differences, and as the root mean square error of 
the regression of eGFR v. mGFR. As measures of accuracy, the root 
mean square error (RMSE) values (calculated as the square root of 
mean (log eGFR – log mGFR)2) and percentages of GFR estimates 
that fell within 30% (P30) and 20% (P20) of the mGFR were calcula-
ted. Bland-Altman analyses[22] were used to determine the agreement 
between eGFR and mGFR. The sensitivity, specificity and positive 
predictive value for identifying individuals with an mGFR <60 mL/
min/1.73 m2 were calculated for each equation. The Shapiro-Wilk 
test was used to test for normality. The McNemar test was used to 
compare proportions.
Statistical analysis was performed using MedCalc Statistical 
Software for Windows v.18.10.2 (MedCalc Software, Belgium (https://
www.medcalc.org), 2018).
Results
In total, 80 participants were included (30 male, median age 39 years, 
full age range 18 - 68 years). Sixty-eight had a diagnosis of CKD, 10 
were potential kidney donors, and 2 were healthy volunteers. The 
median mGFR was 59 mL/min/1.73 m2 (full range 10 - 126 mL/
min/1.73 m2) (Fig. 1 and Table 1).
In 46 individuals, Scr was measured using the Jaffé (alkaline 
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Fig. 1. Study enrolment. (GFR = glomerular filtration rate; Scr = serum 
creatinine.)
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analyser was used. There was no significant difference in bias or 
precision of the equations between the alkaline picrate and enzymatic 
groups (data not shown).
The performance of the GFR estimation equations is shown in 
Table 2. The bias of the MDRD equation was 1.6 mL/min/1.73 m2, 
whereas the CKD-EPI equation overestimated GFR by 7.9 mL/
min/1.73 m2. The RMSE values of the regression of MDRD and 
CKD-EPI v. mGFR were 15.1 and 13.5 mL/min/1.73 m2, respectively, 
whereas the IQR of the differences was narrower for the MDRD 
equation than the CKD-EPI (15.9 v. 20.2 mL/min/1.73 m2). The P30 
values did not differ significantly (MDRD 80.0%, CKD-EPI 72.5%; 
p=0.18). When the black ethnicity factor was applied, bias, precision 
and accuracy of both equations deteriorated. The Bland-Altman 
analyses are shown in Fig. 2. Both equations had non-significantly 
higher P30 values in the subgroup of individuals with a GFR ≥60  mL/
min/1.73 m2 (MDRD 84.6%, CKD-EPI 82.1%) than in the GFR 
<60 mL/min/1.73 m2 subgroup (MDRD 75.6%, CKD-EPI 63.4%). 
For identification of individuals in whom the GFR was <60 mL/
Table 1. Participant characteristics (N=80)
Age (years), median (full range) 39 (18 - 68)
Scr (µmol/L), median (full range) 92 (66 - 191)
Scr (mg/dL), median (full range) 1.0 (0.5 - 7.9)
Measured GFR (mL/min/1.73 m2), median (full range) 59 (10 - 126)
Sex (male), n (%) 30 (37.5)
GFR (mL/min/1.73 m2), n (%)
≥90 27 (33.7)
60 - 89 12 (15.0)
30 - 59 19 (23.8)
<30 22 (27.5) 
Diagnosis/reason for participation, n (%)
Glomerular disease 41 (51.3)
Lupus nephritis 17 (21.3)
Focal segmental glomerulosclerosis 7 (8.7)
IgA nephropathy 4 (5.0)
Membranous nephropathy 3 (3.8)
Other glomerulonephritis 10 (12.5)
CKD of unknown cause 8 (10.0)
Autosomal dominant polycystic kidney disease 5 (6.2)
Malignant hypertension 4 (5.0)
Solitary kidney 3 (3.8)
Obstructive nephropathy 2 (2.5)
Other specified renal disease 5 (6.2)
Potential kidney donor 10 (12.5)
Healthy volunteer 2 (2.5)
Chronic use of trimethoprim* 4 (5.0)
Scr = serum creatinine; GFR = glomerular filtration rate; CKD = chronic kidney disease.
*In 4 of the patients with lupus nephritis.
Table 2. Bias, precision, accuracy, and 95% limits of agreement of the MDRD and CKD-EPI GFR estimation equations
MDRD CKD-EPI
MDRD with black 
ethnicity factor
CKD-EPI with black 
ethnicity factor
Bias
Median difference*† (95% CI) 1.6 (–0.3 - 7.5) 7.9 (5.4 - 11.5) 15.3 (11.1 - 20.3) 20.3 (14.6 - 24.0)
Precision
IQR of the differences*† 15.9 20.2 25.9 28.1
RMSE*‡ 15.1 13.5 18.2 15.7
Accuracy
RMSE§ 0.239 0.257 0.331 0.347
P30, % (95% CI) 80.0 (69.6 - 88.1) 72.5 (61.4 - 81.9) 51.3 (39.9 - 62.6) 47.5 (36.2 - 59.0)
P20, % (95% CI) 60.0 (48.4 - 70.8) 55.0 (43.5 - 66.2) 36.3 (25.8 - 47.8) 31.3 (21.4 - 42.6)
Agreement
95% LOA* –24.9 - 34.4 –17.9 - 35.7 –21.6 - 60.0 –14.5 - 55.2
GFR = glomerular filtration rate (m = measured, e = estimated); MDRD = Modification of Diet in Renal Disease; CKD-EPI = Chronic Kidney Disease Epidemiology Collaboration;  
CI = confidence interval; IQR = interquartile range; RMSE = root mean square error; P30 and P20 = percentages of GFR estimates that fell within 30% and 20%, respectively, of the mGFR;  
LOA = limits of agreement.
*Units mL/min/1.73 m2.
†The differences were calculated as eGFR – mGFR.
‡RMSE of the regression of eGFR v. mGFR.
§RMSE calculated as the square root of mean (log eGFR – log mGFR)2.
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min/1.73 m2, the sensitivities of the MDRD 
and CKD-EPI equations were >90% in the 
three subgroups analysed (Table 3).
Discussion
The performance of both equations was 
satisfactory in this mixed-ancestry SA 
population. The MDRD equation was less 
biased than the CKD-EPI equation, over-
estimating mGFR by 1.6 mL/min/1.73  m2 
compared with 7.9 mL/min/1.73 m2 (p<0.001). 
The IQRs of the differ ences were 15.9  mL/
min/1.73 m2 for the MDRD equa tion and 
20.2 ml/min/1.73 m2 for the CKD-EPI equa-
tion, and the RMSE values were 16.0 and 
16.4  mL/min/1.73 m2, respectively. Accu-
racy was not significantly different, with 
P30 values of 80% and 72.5% (p=0.18). In 
the original CKD-EPI study, the CKD-EPI 
equation was compared with the MDRD 
equation using a large validation set of 6 646 
individuals. [4] Although the majority of 
participants were white and had CKD, the 
population was fairly diverse in terms of 
ethnicity (19% black, ~4% Asian/Hispanic) 
and pathology (29% diabetes, 19% transplant 
recipients, 14% healthy kidney donors). 
The mean GFR was 68 mL/min/1.73 m2. 
The median difference, IQR and P30 of the 
MDRD equation were –5.5 mL/min/1.73 m2, 
18.3 mL/min/1.73 m2 and 80.6%. The CKD-
EPI equation performed marginally better, 
with a bias of 2.5 mL/min/1.73 m2, an IQR 
of 16.6 mL/min/1.73 m2 and a P30 of 84.1%. 
In an earlier study, the MDRD equation was 
evaluated in a large population pooled from 
10 studies (mean GFR 68 mL/min/1.73 m2, 
32% black, 5% Asian/Native American, 
29% diabetes, 5% transplant recipients). [23] 
Median bias was –2.7 mL/min/1.73 m2, 
IQR 16.4 mL/min/1.73 m2 and P30 83%. 
The results in our study, specifically for 
the MDRD equation, are comparable to 
these and some of the other large validation 
studies from North American, European and 
Australian populations.[6]
For identification of individuals with a 
GFR <60 mL/min/1.73 m2, both equations 
performed well, with sensitivities >97% 
and specificities and positive predictive 
values >80%. This is useful information for 
screening programmes or for researchers 
conducting epidemiological studies on the 
prevalence of CKD in local communities. 
Although sensitivity decreased slightly when 
individuals with a GFR <30 mL/min/1.73 m2 
were excluded from the analysis, it remained 
>90% for both equations. For the GFR 
subgroups analysed, the MDRD equation 
tended to perform better than the CKD-
EPI; however, as expected from the small 
numbers in each group, the differences were 
not significant.
A few investigators have evaluated the 
MDRD and CKD-EPI equations in other SA 
populations. One consistent finding across 
all the studies in black South Africans was 
that incorporation of an African American 
ethnicity factor resulted in a substantial 
increase in bias and a decrease in precision 
and accuracy.[7,9-11] It is therefore not 
surprising that similar results were found 
in our mixed-ancestry population (Table 2). 
In a study of 100 black South Africans with 
CKD, the bias, precision and accuracy of 
the MDRD equation were similar to our 
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Fig. 2. Bland-Altman plots of the four equations, MDRD (A), CKD-EPI (B), MDRD with the black 
ethnicity factor (C), and CKD-EPI with the black ethnicity factor (D). The solid line represents the 
mean difference between eGFR and mGFR, and the dashed lines represent the upper and lower limits 
of agreement with 95% confidence intervals. (eGFR = estimated glomerular filtration rate; mGFR = 
measured glomerular filtration rate; MDRD = Modification of Diet in Renal Disease; CKD-EPI = 
Chronic Kidney Disease Epidemiology Collaboration.)
Table 3. Diagnostic performance of the MDRD and CKD-EPI GFR equations in detecting patients with a GFR <60 mL/min/1.73 m2
Sensitivity, % (95% CI) Specificity, % (95% CI) PPV, % (95% CI) NPV, % (95% CI)
All patients (N=80)
MDRD 97.3 (91.0 - 99.6) 88.4 (79.3 - 94.5) 87.8 (78.6 - 94.1) 97.4 (91.1 - 99.7)
CKD-EPI 97.1 (90.7 - 99.6) 82.6 (72.7 - 90.3) 80.5 (70.1 - 88.5) 97.4 (91.1 - 99.7)
GFR 45 - 90 mL/min/1.73 m2 (n=31)
MDRD 93.8 (78.9 - 99.3) 73.3 (54.4 - 87.5) 78.9 (60.6 - 91.4) 91.7 (76.1 - 98.5)
CKD-EPI 92.3 (76.9 - 98.8) 61.1 (42.0 - 78.0) 63.2 (44.1 - 79.7) 91.7 (76.1 - 98.5)
GFR >30 mL/min/1.73 m2 (n=58)
MDRD 93.8 (84.2 - 98.4) 90.5 (79.7 - 96.6) 78.9 (66.2 - 88.5) 97.4 (89.4 - 99.8)
CKD-EPI 92.3 (82.2 - 97.7) 84.4 (72.5 - 92.6) 63.2 (49.5 - 75.5) 97.4 (89.4 - 99.8)
GFR = glomerular filtration rate; MDRD = Modification of Diet in Renal Disease; CKD-EPI = Chronic Kidney Disease Epidemiology Collaboration; GFR = glomerular filtration rate;  
PPV = positive predictive value; NPV = negative predictive value; CI = confidence interval.
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50 black South Africans), the CKD-EPI equation had a median bias 
of 4.9 mL/min/1.73 m2 and a P30 of 74%, values also very similar to 
ours.[8] In a separate study of 91 black South Africans with CKD, bias 
of the MDRD equation was negligible but the precision was poor as 
reflected by the wide 95% limits of agreement in the Bland-Altman 
analyses (–37.9 - 40.0 mL/min/1.73 m2).[10] The P30 of the MDRD 
equation in this study ranged between 36% and 69% depending on 
the GFR. In a more recent study of 188 black South Africans, the P30 
value of the MDRD equation was 53 - 54% and that of the CKD-
EPI equation 53 - 54%, whereas the P30 values in 99 Indian South 
Africans were 49 - 66% and 54 - 66% for the MDRD and CKD-EPI 
equations, respectively.[11] This population included individuals with 
malignancy (58%) and CKD (38%).
Possible reasons for the poorer performance of eGFR in previous 
SA studies include differences in ethnicity, mean GFR, pathology 
and/or methodology. Many other studies in populations outside 
the USA, Europe and Australia have shown similarly poor results, 
and in most cases these have been attributed to ethnic differences.[6] 
Although South Africans of mixed ancestry are genetically diverse, 
with Khoisan (32 - 43%), Bantu-speaking African (20 - 36%), 
European (21 - 28%) and Asian (9 - 11%) ancestral components,[14] 
this diversity did not significantly limit eGFR performance in this 
population. Furthermore, the fact that some studies in black Africans 
with CKD had similar results suggests that ethnicity may be less 
important than other factors.[7,8]
Possibly one of the most important determinants of the effective-
ness of eGFR equations is patient pathology. The population in our 
study comprised CKD patients (85%) and healthy individuals (15%), 
a composition similar to the development populations of the MDRD 
and CKD-EPI equations, which is likely to have contributed towards 
the good performance of the equations in our study. In contrast, in 
the most recent of the SA studies, 58% of patients had cancer.[11] A 
lower average Scr concentration in this population[11] may explain 
the positive bias found for both MDRD and CKD-EPI equations, as 
cancer and other chronic illnesses are known to reduce creatinine 
generation through muscle wasting.[24]
In the measurement of GFR, factors such as the use of a different 
filtration marker or method to calculate GFR will result in systematic 
differences in mGFR; however, provided measurement of GFR is 
performed correctly, the effect should be small. This is because the 
error on eGFR – mGFR is equal to √[(error on eGFR)2 + (error on 
mGFR)2], so if the error in mGFR << error in eGFR, the latter would 
contribute little to the error on the difference. In the present study, 
meticulous care was paid to methodology for GFR measurement. 
Our departmental guideline adheres strictly to the 2004 British 
Nuclear Medicine Society GFR guideline,[17] and we perform rigorous 
quality control checks on each GFR study. Furthermore, an analysis 
of measurement errors in our unit, taking into account error in all 
aspects of the investigation (e.g. measuring patient height and weight, 
preparation of the standard, measuring of doses, recording of time, 
pipetting technique and counting of samples), revealed an error in 
mGFR of ~2 mL/min/1.73 m2.[25]
All participants in the present study were screened meticulously by 
a renal physician, a factor that may contribute to the relatively good 
performance of eGFR. Patients with expanded extracellular fluid 
volumes (ascites, oedema or pleural effusions), acute renal failure, 
any acute concurrent illness, or any other reason to suspect unstable 
kidney function were not considered for inclusion. Furthermore, 
GFR and Scr were measured on the same day in every patient. 
Although fluctuations in Scr may to a degree mirror fluctuations in 
GFR, with coefficients of variation (CV) for repeat measurements 
of ~8 - 10% for GFR and 6% for Scr,[17,26] measurement of these 
parameters on different days will limit the precision that is attainable. 
Use of a Jaffe assay rather than an enzymatic method for creatinine 
measurement will further limit the precision considering analytical 
CVs of ~5.5% and 2%, respectively.[26]
Study limitations
The main limitation of this study is the sample size; however, the study 
was sufficiently powered to draw conclusions about the performance 
of the equations in the population. The primary outcome variable 
is the P30 proportion. A sample size of 80 is suffi cient to estimate 
the true population value of P30 using a 95% confidence interval 
(CI) to within 10% of the true value (i.e. a CI width of 20%), given 
that the P30 is 70 - 80%. While a better estimation of P30 is ideal, an 
estimation within 10% can be regarded as acceptable. On the other 
hand, a sample size of ~150 would be required to detect a significant 
difference between the MDRD and CKD-EPI equations at P30 values 
of 80% and 72.5%, respectively. It therefore cannot be concluded that 
the MDRD equation outperformed the CKD-EPI equation in this 
study. Ideally, more patients with normal kidney function would have 
been included. This might have resulted in better performance of the 
CKD-EPI equation, as (i) the MDRD equation has been shown to 
have poorer accuracy at higher GFR levels,[23] and (ii) the CKD-EPI 
equation was found to be more accurate than the MDRD in most 
GFR subgroups.[27] Based mainly on a CKD population, our results 
are not necessarily generalisable to other populations, e.g. patients 
with cancer. Four of the patients with lupus nephritis who were 
included used trimethoprim chronically. Trimethoprim is known 
to interfere with the tubular secretion of creatinine, thus raising Scr 
levels.[28] However, the effect of this factor on the overall results of the 
study is thought to be minimal.
Conclusions
The MDRD and CKD-EPI equations have both shown satisfactory 
performance in this SA mixed-ancestry adult population, with 
comparable accuracy. This information is reassuring to physicians 
treating patients with CKD and to researchers conducting 
epidemiological studies.
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